Park Ha Biological Technology Co., Ltd. Ordinary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BYAH research report →
Price Chart
About the company
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.
- CEO
- Xiaoqiu Zhang
- IPO
- 2024
- Employees
- 41
- HQ
- Wuxi, JS, CN
Get TickerSpark's AI analysis on BYAH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.21M
- P/E
- -0.03
- PEG
- -0.00
- P/S
- 0.58
- P/B
- 0.34
- EV/EBITDA
- -0.23
- Div Yield
- 0.00%
- Gross Margin
- 89.94%
- Op Margin
- -212.16%
- Net Margin
- -214.17%
- ROE
- -174.17%
- ROIC
- -145.22%
Latest fiscal year · YoY change
- Revenue
- $2.52M+6.0%
- Gross Profit
- $2.38M+9.0%
- Op Income
- $-24,148,901
- Net Income
- $-24,364,753-5191.3%
- EPS
- $-331.04-4622.4%
- OCF Growth
- -91.1%
- FCF Growth
- -100.3%
- 52W High
- $254.80
- 52W Low
- $2.56
- 50D MA
- $5.72
- 200D MA
- $33.60
- Beta
- 0.18
- RSI (14)
- 39
- Avg Volume
- 912.35K
No earnings-call transcripts are available for BYAH yet.
- Free Float
- 41.4%
- Shares Outstanding
- 747.90K
- Float Shares
- 309.41K
of shares held by institutions
2 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 3, 26 | Wang Li (Alya) | other | 0 |
| Aug 3, 26 | Zhu Xiaoyan | other | 112,500 |
| Dec 30, 24 | Shan Yanan | other | 0 |
| Dec 30, 24 | Li Xinyu | other | 0 |
| Dec 30, 24 | Yu Xiaozhong | other | 0 |
| Dec 30, 24 | Zhu Xiaoyan | other | 0 |
| Dec 30, 24 | Zhang Xiaoqiu | other | 0 |
| Dec 30, 24 | Sheng Qixiong | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BYAH coverage
Recent articles, reports, and earnings notes.
No research on BYAH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BYAH report →BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact SueWallSt
gurufocus.com · Aug 20
BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact SueWallSt
prnewswire.com · Aug 20
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH
prnewswire.com · Aug 20
Park Ha Biological Technology Co, Ltd. Stockholders Have an Opportunity to Lead the Class Action Against BYAH- Contact Robbins LLP for Information About Recovering Your Losses
gurufocus.com · Aug 19
Park Ha Biological Technology Co, Ltd. Stockholders Have an Opportunity to Lead the Class Action Against BYAH- Contact Robbins LLP for Information About Recovering Your Losses
prnewswire.com · Aug 19
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
globenewswire.com · Aug 19
BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact Levi & Korsinsky
prnewswire.com · Aug 19
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com · Aug 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.